Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
182.01
-1.62 (-0.88%)
At close: Mar 6, 2026, 4:00 PM EST
182.22
+0.21 (0.12%)
After-hours: Mar 6, 2026, 7:38 PM EST
Jazz Pharmaceuticals Employees
Jazz Pharmaceuticals had 2,890 employees as of December 31, 2025. The number of employees increased by 90 or 3.21% compared to the previous year.
Employees
2,890
Change (1Y)
90
Growth (1Y)
3.21%
Revenue / Employee
$1,476,673
Profits / Employee
-$123,235
Market Cap
11.20B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Ionis Pharmaceuticals | 1,402 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
| Madrigal Pharmaceuticals | 915 |
| BridgeBio Pharma | 839 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
JAZZ News
- 4 days ago - Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 9 days ago - Jazz Pharmaceuticals: Relief Rally On 2026 Oxybate Franchise's Outlook - Seeking Alpha
- 10 days ago - Jazz Pharmaceuticals plc (JAZZ) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance - PRNewsWire
- 18 days ago - Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences - PRNewsWire
- 25 days ago - Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026 - PRNewsWire
- 7 weeks ago - Jazz Pharmaceuticals plc (JAZZ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer - GlobeNewsWire